13 July 2023
13 July 2023
The Commission has issued approximately €432m to Illumina for breach of EU merger rules.
The synthetic biology company supplies genes to the pharmaceutical and biotechnology industries.
The sensor is implanted into the body’s largest vein to help monitor total body fluid.
The device can share ultrasound images throughout the care team, which enables better patient diagnosis.
Verve takes a different approach for its renal denervation system, as the treatment space gains momentum in 2023.
Supported by NHS England, the cardiac disease diagnostic technology pilot is being conducted in five NHS trusts.
With the test, clinicians will be able to differentiate between BPH and aggressive prostate cancer at the initial screening time.
The data from the studies will be used to apply for 510(k) clearance for the system from the FDA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
